Search Within

GDMT, Medicine

Formats
  1. Journal Article (927)
  2. Meeting Abstract (829)
  3. Review (48)
  4. Book Section (38)
  5. Editorial (29)
  6. Guidelines (19)
  7. Correspondence (7)
  8. Research Letter (1)
Groups
  1. Gynecology Disease Management Team (1898)
  2. Department of Medicine (1888)
  3. Solid Tumor Oncology Division (1887)
  4. Gynecologic Medicine Service (1847)
  5. Surgery (582)
  6. GDMT, Surgery (465)

More Groups

People
  1. Carol Aghajanian (613)
  2. Martee Hensley (290)
  3. Nadeem Abu-Rustum (279)
  4. Roisin O'Cearbhaill (272)
  5. Vicky Makker (267)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (61)
  2. 2024 (159)
  3. 2023 (165)
  4. 2022 (196)
  5. 2021 (146)
  6. 2020 (173)

More Years

Publications
  1. Journal of Clinical Oncology (417)
  2. Gynecologic Oncology (416)
  3. International Journal of Gynecological Cancer (151)
  4. Annals of Oncology (106)
  5. Clinical Cancer Research (64)
  6. Cancer (37)

More Publications

Publishers
  1. Elsevier Inc. (496)
  2. American Society of Clinical Oncology (449)
  3. Lippincott Williams & Wilkins (176)
  4. American Association for Cancer Research (139)
  5. Oxford University Press (128)
  6. Nature Publishing Group (73)

More Publishers

Results (1898)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Imaging HER2-positive metastatic esophagogastric cancer with (89)Zr-trastuzumab PET and (18)F-FDG PET
    Meeting Abstract

    Lumish, M. A.; Maron, S. B.; Paroder, V.; Philemond, S.; O'Donoghue, J. A.; Schoder, H.; Lewis, J. S.; Janjigian, Y. Y.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Disparities in pan-cancer patients undergoing germline cancer risk assessment by self-reported race/ethnicity and ancestry
    Meeting Abstract

    Liu, Y. L.; Maio, A.; Kemel, Y.; Salo-Mullen, E. E.; Sheehan, M.; Tejada, P. R.; Trottier, M.; Fleischut, M. H.; Latham, A.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A nutritional management algorithm in older patients with locally advanced esophageal cancer
    Meeting Abstract

    Moy, R. H.; Sabwa, S.; Maron, S. B.; Shcherba, M.; Apollo, A. J.; Janjigian, Y. Y.; Ku, G. Y.; Tew, W. P.; Ilson, D. H.; Won, E.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Provision of subspecialized expert oncology (SEO) opinions using Navya Cancer Data Model (NCDM), a technology-based platform: Prospective study to facilitate access to care
    Meeting Abstract

    Traina, T. A.; Kantoff, P. W.; Matasar, M. J.; Dunn, L.; Friedman, C. F.; Voss, M. H.; Seidman, A. D.; Cahlon, O.; Zauderer, M. G.; Manship, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer
    Journal Article

    Navitski, A.; Al-Rawi, D. H.; Liu, Y.; Rubinstein, M. M.; Friedman, C. F.; Rampal, R. K.; Mandelker, D. L.; Cadoo, K.; O'Cearbhaill, R. E.
    Gynecologic Oncology Reports (2021)

    Fulltext@MSK | Save
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; Rivière, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: A multicentre, single-arm, phase 2 trial
    Journal Article

    Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V. E.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Attributions of survival and methods of coping of long-term ovarian cancer survivors: A qualitative study
    Journal Article

    Ketcher, D.; Lutgendorf, S. K.; Leighton, S.; Matzo, M.; Carter, J.; Peddireddy, A.; Karlan, B. Y.; Tew, W. P.; Sood, A. K.; Shinn, E. H.
    BMC Women's Health (2021)

    Fulltext@MSK | Save
  • Association of homologous recombination deficiency (HRD) with clinical outcomes in a phase III study of olaparib or cediranib and olaparib compared to platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer (PSOC): Biomarker analyses from NRG-GY004
    Meeting Abstract

    Swisher, E.; Miller, A.; Kohn, E.; Brady, M.; Radke, M.; Pennil, C.; Khasnavis, N.; Buscema, J.; Tew, W.; Muller, C.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Gavocabtagene autoleucel (gavo-cel, TC-210) dose escalation in refractory mesothelin-expressing solid tumors
    Meeting Abstract

    Hong, D. S.; SciMentum, S. L.; Tanyi, J.; MacMullen, L.; Jalbert, L.; Muzithras, V. P.; Zikaras, K.; Cao, L.; O'Cearbhaill, R. E.; Quintás-Cardama, A.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save